LP22 : Phase 1 results from PXS-4728A, a selective SSAO/VAP-1 inhibitor, for the treatment of non-alcoholic steatohepatitis

标题
LP22 : Phase 1 results from PXS-4728A, a selective SSAO/VAP-1 inhibitor, for the treatment of non-alcoholic steatohepatitis
作者
关键词
-
出版物
JOURNAL OF HEPATOLOGY
Volume 62, Issue -, Pages S274-S275
出版商
Elsevier BV
发表日期
2015-06-11
DOI
10.1016/s0168-8278(15)30176-8

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now